Functional anatomy of the colonic bioreactor: Impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders  by Swidsinski, Alexander et al.
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Sections  of fecal  cylinders  were  analyzed  using  ﬂuorescence  in  situ hybridization  targeting  180  bac-
terial  groups.  Samples  were  collected  from  three  groups  of  women  (N = 20 each)  treated  for  bacterial
vaginosis  with  ciproﬂoxacin  + metronidazole.  Group  A only  received  the  combined  antibiotic  regimen,
whereas  the  A/Sb  group  received  concomitant  Saccharomyces  boulardii  CNCM  I-745 treatment,  and  the
A Sb group  received  S. boulardii  prophylaxis  following  the  14-day  antibiotic  course.  The  number  of  stool
cylinders  analyzed  was  188  out  of  228  in  group A,  170 out  of 228  in group  A/Sb,  and  172  out  of  216 in
group  A  Sb.
The  colonic  biomass  was organized  into  a separate  mucus  layer  with  no  bacteria,  a 10–30  m  broad
unstirred  transitional  layer  enriched  with  bacteria,  and  a patchy  fermentative  area  that  mixed  digestive
leftovers  with bacteria.  The  antibiotics  suppressed  bacteria  mainly  in the  fermentative  area,  whereas
abundant  bacterial  clades  retreated  to the  transitional  mucus  and  survived.  As  a result,  the total  con-
centration  of bacteria  decreased  only  by one  order.  These  effects  were lasting,  since  the overall  recovery
of  the  microbial  mass,  bacterial  diversity  and  concentrations  were  still below  pre-antibiotic  values  4
months  after  the  end  of  antibiotic  treatment.  Sb-prophylaxis  markedly  reduced  antibiotic  effects  and
improved  the  recovery  rates.  Since  the  colon  is  a sophisticated  bioreactor,  the study  indicated  that  the
spatial  anatomy  of  its biomass  was  crucial  for  its  function.
©  2015  The  Authors.  Published  by Elsevier  GmbH.  This  is an  open  access  article  under  the  CC  BYntroduction
Antibiotics have changed microbiology profoundly in the last
00 years. However, although they can help to defeat infections,
ntibiotics can also devastate bacterial communities involved in
he maintenance of normal body functions [1]. The well-reviewed
linical symptoms of antibiotic induced shifts in the microbiome of
he colon are especially manifest and they can be extremely severe
6,18]. Despite a long history of problems, changes in the micro-
iota are poorly characterized and their interactions with colonic
ucus are completely unknown. The studies prior to the 1970s
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erlin, Germany. Tel.: +49 30 450 514 003; fax: +49 30 450 514 033.
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723-2020/© 2015 The Authors. Published by Elsevier GmbH. This is an open access articlicense  (http://creativecommons.org/licenses/by/4.0/).
used culture methods, which are inadequate for the monitoring of
polymicrobial communities. Nevertheless, they demonstrated that
antibiotics massively altered the colonic microbiota. Subsequently,
the development of molecular methods extended our perception of
the diversity and abundance of colonic microorganisms [12]. They
were, however, mainly focused on identiﬁcation of the microbiota
involved because of the high costs related to animal [9] and single
patient [4] studies.
We have routinely used ﬂuorescence in situ hybridization (FISH)
with rRNA-targeted oligonucleotide probes for the monitoring of
intestinal [15] and vaginal [16] microbiota in the Outpatient Clinic
for Polymicrobial Infections and Bioﬁlms of the Charité Hospital in
Berlin, Germany since 2009. The colonic microbiota is visualized
in parafﬁn sections of ﬁxed stool-cylinders, which are collected by
the patients with a weekly to monthly frequency, depending on
the clinical aim. The spatial differences in bacterial growth in the
le under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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enter of the feces or on the mucus-feces interface provide informa-
ion on the host microbial interactions during the process of colonic
ermentation. Usually, each stool cylinder is evaluated with FISH
robes for 6–8 of the most informative bacterial groups. However,
he number of bacterial groups investigated can be increased to
00–400 depending on the question to be answered. This approach
as shown diagnostic efﬁciency in patients with ulcerative colitis,
rohn’s disease, irritable bowel syndrome and other gastrointesti-
al disorders. To date, we have investigated over 35,000 fecal
ylinders.
A critical aspect in the evaluation of the colonic microbiota is the
mpact of concomitant antibiotic therapy, since both disease and
ntibiotics alter the colonic microbiota. Polymicrobial infections
re also common in uro-vaginal disorders. Bacterial vaginosis (BV)
s a local, non-lethal, persistent, extra-intestinal infection related
o a Gardnerella-dominated bioﬁlm. The disease occurs in 10–20%
f sexually active women. The microbial diagnosis requires sophis-
icated culture-independent methods and is, in practice, deduced
rom indirect criteria, including clinical symptoms, pH and bac-
erial appearance in native or Gram-stained vaginal smears. The
ymptoms respond well to antibiotics, but recur in 60–70% of
atients within weeks, leading to repeated antibiotic use. This par-
icular group of patients then requires measures for monitoring
nd preventing colonic dysbiosis because of frequent antibiotic
se. Therefore, we decided to intensify the surveillance of the
olonic microbiota (intervals and number of microbial FISH probes)
n a group of women treated with antibiotics for BV and eval-
ate the additional prophylactic use of Saccharomyces boulardii
Sb). Saccharomyces boulardii CNCM I-745 has been proven to be
ffective in the treatment of diarrhea [3] and is the only probio-
ic approved as a drug in most countries of the European Union
11].
aterials and methods
atients and samples
Patients were considered eligible for the present study at the
harité University Hospital if they had persistent bacterial vagi-
osis (BV), and if treatment was indicated according to current
uidelines CDC, 2010.
The diagnosis of BV in symptomatic women was  con-
rmed using FISH in three consecutive urine samples collected
onthly, which is an approach that has an excellent diagnos-
ic accuracy compared to the Nugent score-based diagnosis, as
escribed previously [19]. Bioﬁlms were detected on desqua-
ated vaginal epithelial cells that are abundantly present in urine
ediments.
All subjects gave their informed consent. The collection of fecal
nd urine samples for FISH diagnosis of dysbiosis was approved by
he ethics commission of the Charité University Hospital.
In this study, BV was treated with a combination of oral metro-
idazole (3 × 400 mg  day−1) and ciproﬂoxacin (2 × 500 mg  day−1)
or 2 weeks. For prophylaxis with Saccharomyces boulardii CNCM I-
45 [Perenterol®, Biocodex], one 250 mg  capsule three times daily
or 2 weeks was used.
Patients were randomly assigned to one of three groups (N = 20
ach): women in Group A received the combined antibiotic regimen
ut no probiotics; women in Group A/Sb received prophylaxis with
. boulardii that was initiated concomitantly with antibiotic treat-
ent; and women in Group A Sb received S. boulardii following the
4-day antibiotic course.
Three consecutive stool samples were collected monthly prior
o therapy. Two  stool samples were collected weekly during antibi-
tic therapy on days 7 and 14, and four samples were collectedied Microbiology 39 (2016) 67–75
every 2 weeks after cessation of antibiotic treatment. Thereafter,
2–3 samples were collected monthly. A loss of a maximum of 3
samples for liquid stools (maximum of one in each period) was
tolerated. However, liquid stools were uncommon in persons with
a healthy gut and no patient was removed from the study for this
reason, even during antibiotic treatment. This approach resulted
in 9–12 stool samples per patient (days −60, −30, 0, 7, 14, 28,
42, 56, 70, 100, 130, and 160 as related to the start of antibiotic
therapy).
The patients collected the stool samples themselves. The
4–10 mm long stool cylinders were punched-out from the stool
using plastic drinking straws with an inside diameter of 3 mm.
The drinking straws were pre-cut to 4 cm in length and handed
out to the study participants together with 50 mL  Falcon tubes
ﬁlled with 20 mL  Carnoy solution (6/6/1 vol. ethanol/glacial acetic
acid/chloroform). The pieces of drinking straw with the stool inside
were dropped immediately into the 50 mL  Falcon tube, ﬁxed in
Carnoy solution for at least 24 h at room temperature and deliv-
ered to the laboratory within two  weeks, as previously described
[15].
FISH
Colonic microbiotas were investigated using structure func-
tional FISH analysis of Carnoy ﬁxed and parafﬁn-embedded stool
cylinders [15]. Multicolor ﬂuorescence in situ hybridization (FISH)
simultaneously using three differently stained FISH probes (C3 –
orange, FITC-dobe – green, C5 – dark red) counterstained with DAPI
to reveal DNA structures was  performed on 4 m longitudinally
cut sections of punched stool cylinders. Sections were placed on
SuperFrostTM Plus slides.
A Nikon e600 ﬂuorescence microscope was used, and the images
were photo documented with a Nikon DXM 1200F color camera and
software (Nikon, Tokyo, Japan).
Bacteria were quantiﬁed using group-speciﬁc C3 probes. The
FITC-marked universal probe was used in each hybridization to
evaluate the total number of bacteria, and the C5-marked probe
with a different probe speciﬁcity than C3 was used to deter-
mine the spatial relationship of different bacterial groups to each
other.
Only signals that hybridized with a speciﬁc FISH probe and the
universal FISH probe but did not hybridize with speciﬁc FISH probes
from unrelated bacterial groups were evaluated [13].
Bacterial concentrations of homogeneous populations were
enumerated visually in one of the 10 × 10 ﬁelds of the ocular raster
corresponding to 10m × 10 m of the section surface at a mag-
niﬁcation of ×1000. This number was  assigned to a concentration
of 109 bacteria/mL, which was the most equivalent to a calculation
formula used previously [15].
In case of uneven distribution of bacteria over the microscopic
ﬁeld, the positive signals were enumerated in 10 ﬁelds of the ocular
raster along the distribution gradient and an average was used after
dividing by 10.
Bacterial groups and FISH probes investigated
A total of 180 bacterial FISH probes available from public
resources [10] were applied. Hybridizations were performed with
all probes (Table 1 and Table S1), but 31 of these probes were
excluded from the analysis (Table S1) because they showed mul-
tiple uncharacteristic signals, both in form and distribution. These
probes did not cross-react with any of the related bacterial groups,
or the seven FISH probes that were identical to the related probes
for the same species.
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Table  1
Applied FISH probes.
Substantial groups
Essential (N = 3)
Erec482 (Eubacterium rectale,  Clostridium coccoides group)
Bac303 (most Bacteroidaceae)
Fprau (Faecalibacterium prausnitzii)
Individual Pioneer (N = 5)
Bif153 Genus Biﬁdobacterium
Cdif198 Clostridium difﬁcile
Clit135 Clostridium lituseburense group including C. difﬁcile
Ebac1790 Enterobacteriaceae
GAM42a Gammaproteobacteria
Complementary (N = 39)
ACA652/ACA23A Acinetobacter
ACI623 Acidaminococcaceae sp. (not the Selenomonas species)
AKK406 Akkermansia
Ato291 Atopobium cluster
Bcat187 Biﬁdobacterium. catenulatum group
Bcv13b Burkholderia vietnaminsis, Burkholderia cepacia
Bdis656 Bacteroides distasonis
Bifado434 Biﬁdobacterium. adolescentis
Blon1004 Biﬁdobacterium. longum
Bputre698 Bacteroides putredinis
Burkho Burkholderia spp.
Ceut705 Coprococcus eutactus, Coprococcus sp.
Chis150 Clostridium histolyticum
Cor653 Coriobacterium group
Cvir1414 Clostridium viride group
DSS658 Desulfobacteraceae and others
Ecyl387 Eubacterium cylindroides
Ehal1469 Eubacterium hallii
HEL274 Helicobacter sp., Wolinella sp.
Lab158 Lactobacillus sp., Enterococcus sp.
Lach571 Lachnospira multipara
LGC354b Firmicutes (Gram-positive bacteria with low G+C content)
MIT447 Streptococcus mitis
Muc1437 Akkermansia muciniphila
Myc657 Mycobacterium subdivision (mycolic acid-containing Actinomycetes)
Pce  Burkholderia spp.
Phasco741 Phascolarctobacterium faecium
Pnig657 Prevotella nigrescens
ProCo1264 Ruminococcus productus
Rbro730 Clostridium sporosphaeroides, Ruminococcus bromii,  Clostridium leptum
Rﬂa729 Ruminococcus albus
SFB1 Segmented ﬁlamentous bacteria
SNA Sphaerotilus natans
SPH492 Sphingomonas,  Erythrobacter
Strc493 most Streptococcus spp.
SUBU1237 Burkholderia spp., Sutterella spp.
TT1372 Treponema
Urobe63a Ruminococcus obeum-like
Ver620 Verrucomicrobium
The names of the FISH probes are listed according to abbreviations of the
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grobeBase online resource http://www.microbial-ecology.net/probebase/default.
sp?mode=search). The Fprau probe is described in [20].
tatistical analysis
Differences between groups were evaluated using the
ann–Whitney U test. Data are presented as means ± SD and
 < 0.05 was considered to be statistically signiﬁcant.
esults
One woman in group A, one women in group A/Sb and two
omen in group A Sb discontinued the antibiotic therapy after 3–5
ays because of side-effects, in particular, nausea (n = 3) accompa-
ied by diarrhea (n = 2) and a facial rash (n = 1). The remainder of
he participants completed the antibiotic therapy and Sb prophy-
axis without noteworthy side-effects. Hence, complete data could
e obtained from 19, 19 and 18 women in the A, A/Sb,  and A Sb
roups, respectively. The number of stool cylinders analyzed wasFig. 1. Composition of colonic microbiota.
188 out of 228 in group A, 170 out of 228 in group A/Sb,  and 172
out of 216 in group A Sb.
Microbiota in the pre-antibiotic period
Occurrence, concentrations and variability
Single bacterial groups could be divided into categories denom-
inated substantial or accidental, depending on their prevalence,
abundance and distribution in the stool cylinder. Substantial groups
occurred in at least 20% of the population at concentrations of >109
bacteria/mL in at least one of the samples. Accidental bacterial
groups occurred in less than 10% of the fecal samples in concen-
trations never reaching 109 bacteria/mL and in most cases lower
than 107 bacteria/mL.
Within the substantial groups, bacteria detected with the EREC,
Bac, and Fprau FISH probes (mainly Roseburia, Bacteroides,  Faecal-
ibacterium prausnitzii)  were consistently present in each sample of
each person at concentrations between 8 × 109 and 30 × 109 bac-
teria/mL. Therefore, the invariability and predominance of these
bacterial groups in humans was obviously essential for colonic
fermentation, and they were denominated the essential bacteria.
However, in earlier publications, we  have used the term “habitual”
in order to stress the obligate presence of these groups in healthy
persons.
All other substantial groups were present in only some patients,
and they were denominated individual substantial groups. Since
their concentrations could reach 1010 bacteria/mL, they added
signiﬁcantly to the colonic microbiome, together comprising
approximately 50% of the biomass.
Pioneer species were subgroups of individual substantial bacte-
ria with preferential growth after antibiotic-induced suppression
of colonic microbiota, but they will be described later.
The resulting study-related classiﬁcation of microbial groups is
shown in Fig. 1.
Individual microbial proﬁle
The individual substantial bacterial groups were either per-
manently present or absent in the three monthly collected fecal
samples prior to therapy in 93% of the subjects, while in 7% they
were transient.
The consecutive presence, absence or transience of colonization
by individual substantial bacteria was  unique for each person and
constructed a characteristic stable individual microbial proﬁle.
Anatomy of the colonic bioreactor
The fecal cylinder included a superﬁcial mucus layer, a transi-tional layer and a fermentation area (Fig. 2). Bacteria were absent or
only sporadically present in the 10–100 m broad external mucus
layer, and highly concentrated in the fermentation area and tran-
sitional mucus.
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Fig. 2. Spatial setup of the colonic bioreactor: Hybridization with Bac303 (Bac-
teroides) Cy3 (orange ﬂuorescence) probe, patient AG, day −30. The interior of the
colonic bioreactor is composed of three zones: a 10–100 m broad separating mucus
layer lacking bacteria (white arrow); a 10–30 m broad transitional mucus layer
homogeneously inﬁltrated by bacteria of the substantial groups (blue arrow); and a
central fermenting area. The central fermenting area merges rich nutrient digestive
leftovers and gas vacuoles with fermentative pulp. The mucus of the separating
and  transitional layer does not include digestive leftovers. Substantial bacterial
groups are highly concentrated in the transitional layer. The luminescence of their
ﬂuorescence is accentuated on contact with mucus (yellow arrows). In fact, the fer-
mentative pulp (demarcation with a yellow line) represents the offshoots of the
transitional layer spreading between digestive leftovers. For background ﬂuores-
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one order of magnitude (Fig. 3A, Table 2A).ence, the mucus can be seen as a shadow framing the outer portion of the stool
ylinder.
The change from bacteria-free mucus to mucus occupied
y bacteria was abrupt, with bacterial concentrations jumping
rom zero to a maximum without any perceptible gradient. This
brupt change generated a bacterial front that lined the border
etween separating mucus and the rich bacterial transitional
rea on the mucosal side of the fecal cylinder. The intensity
f ﬂuorescence was accentuated along the line of the bacterial
ront, demonstrating optimal growth conditions and bacterial
etabolism on contact with the mucus. At 10–40 m behind this
ront, bacteria were evenly distributed within a homogeneous
elt of transitional mucus, which contrasted with the irregularly
omposed fermentation area.
Fermentation needs both substrates and bacteria that are
oticeable ideally as soon as the spatial structure of the stanced
ecal cylinders is evaluated. The fermentation area had an appear-
nce of corned meat in which microbial pulp was intermixed with
izarrely formed and structured particles of digestive leftovers
nd gas vacuoles. Unlike the mucosal side, the change from the
omogeneous transitional mucus to the patchy fermentation area
as irregular. Transitional mucus contained multiple offshoots,
hich intruded more or less deep into the interior of the fermen-
ation area. The bacterial gradient extended from the rich bacterial
ransitional mucus to leftovers of the fermentation area. In fact,
he microbial fermentation pulp could be regarded as detached
ranches of the transitional mucus inseminating the digestive left-
vers (Fig. 2).
The distribution of the bacterial groups between the transitional
ayer and the fermentation area depended on whether they were
ubstantial or accidental. Accidental bacteria avoided the transi-
ional layer, and remained solitary or formed small groups within
he stirred fermenting area. No preference for their location to any
peciﬁc region could be perceived, whereas substantial bacterial
roups were located in both the fermentation and transitional
reas.ied Microbiology 39 (2016) 67–75
The bacterial front arising from transitional mucus had a dif-
ferent position for the single substantial groups: Verrucomicrobia
(Muc, Akk, Hel274) were found to be most external, followed by
Enterobacteriaceae (Ebac, Gam) and then Roseburia (EREC), while
Bacteroides (Bac303) and Biﬁdobacteriaceae (Bif153, Bif164) were
most internal toward the center of the fecal cylinder, leading to
the impression that Verrucomicrobia preferred mucus, whereas Biﬁ-
dobacteriaceae avoided the mucus [15]. However, since none of
the substantial groups demonstrated suppression on contact with
mucus, and all substantial bacterial groups exhibited preferential
growth and accentuation of ﬂuorescence within the transitional
area, the correct interpretation should be that substantial bacte-
rial groups differed in their ability to penetrate the mucus, drifted
apart and imitated a natural “gel electrophoresis” while occupying
their group-speciﬁc levels.
Antibiotic-induced changes
Antibiotics markedly suppressed most of the substantial bacte-
rial groups (Table S2). The suppression lasted an average of two
weeks after discontinuing the antibiotic treatment. Recovery then
became perceptible after six weeks and was  gradual thereafter.
However, the mean concentrations of most substantial bacterial
groups were still below the initial values at follow-up, 130–160
days after antibiotic treatment.
The recovery dynamics were different for Enterobacteriaceae
(Ebac/Gam), Biﬁdobacteriaceae (Bif153) and Clostridium litusebu-
rense/difﬁcile (Clit135/Cdif198), since their mean concentrations
increased exponentially after discontinuing the antibiotics, and the
maximum concentrations were observed two  to four weeks post-
antibiotic treatment approximately doubling the pre-antibiotic
values. The concentrations decreased likewise exponentially as
soon as the recovery of other substantial bacterial groups began,
starting with week six.
The dynamic of the accidental bacterial groups was opposite to
all substantial bacteria. The incidence and concentrations of acci-
dental bacterial groups increased during antibiotic treatment and
declined afterwards, but the concentrations remained extremely
low and occurrence was  restricted to isolated samples.
To make the tendencies of the dynamics more obvious, the
concentrations of essential, individual substantial and acciden-
tal bacteria were added for each patient and the dynamics of
the mean values were analyzed within each group separately for
each corresponding microbiota. Furthermore, Enterobacteriaceae,
Biﬁdobacteriaceae and Clostridium lituseburense/difﬁcile were com-
bined and moved to a separate subgroup of pioneer species.
Essential microbiota
Essential bacterial groups were predominant in all samples
prior to antibiotic treatment but the complete disappearance of
the essential bacteria in some samples during antibiotic treatment
was especially striking. Faecalibacterium prausnitzii was most vul-
nerable, disappearing in approximately 30% of the samples, while
Bacteroides and Roseburia disappeared in 5–15% of the samples
(Groups A and A Sb).  In patients with concomitant S. boulardii treat-
ment (A/Sb),  the Bacteroides and Roseburia groups were not affected
and F. prausnitzii was  less affected, being lost in only 16% as com-
pared to 29% in patients without Sb.
The prompt decrease and complete disappearance of the
essential groups in samples collected during antibiotic treatment
resulted in a global decline of bacterial numbers by approximatelyDespite this comparatively moderate reduction, post-antibiotic
recovery was  slow and had no resemblance to the exponen-
tial growth typical for batch cultures. Two  weeks after antibiotic
A. Swidsinski et al. / Systematic and Applied Microbiology 39 (2016) 67–75 71
dividu
t
s
i
o
o
b
a
o
o
(
p
v
w
c
a
I
g
c
v
t
i
t
P
r
s
W
s
v
tFig. 3. Shifts in total concentrations of (A) Essential bacterial groups; (B) In
reatment, the concentrations of the essential bacteria remained
imilar low as at the time of antibiotic treatment. The ﬁrst increase
n concentrations was only statistically different from values
btained during antibiotic treatment eight weeks post antibi-
tic treatment. The bacterial concentrations remained signiﬁcantly
elow initial values after day 130 in the group receiving antibiotics
lone.
Saccharomyces boulardii modiﬁed the post-antibiotic recovery
f the colonic microbiota markedly.
The decrease in bacterial concentrations was signiﬁcantly less
bvious in patients receiving S. boulardii together with antibiotics
group A/Sb)  compared to the other two groups. The recovery in
atients receiving Sb after antibiotic treatment (group A Sb)  was
ery quick initially, reaching pre-antibiotic concentrations after 4
eeks (Fig. 3A, Table 2A). This was the only group of patients where
oncentrations of essential bacteria reached pre-antibiotic values
t the end of the observation after day 130.
ndividual substantial microbiota
The total concentration of 39 individual substantial bacterial
roups was similar or slightly higher compared to the total con-
entration of the essential substantial bacteria. Despite the large
ariation in occurrence and concentrations of single individual bac-
erial groups, the temporal shift curves in total biomass of the
ndividual substantial bacteria were similar to those observed in
he essential microbiota (Fig. 3B, Table 2B).
ioneer species
The decline in concentrations of Biﬁdobacteriaceae,  Enterobacte-
iaceae and C. lituseburense/difﬁcile groups was identical to all other
ubstantial groups, however, the recovery curves were different.
ithin the ﬁrst two weeks post-antibiotic treatment, the pioneerpecies doubled their concentrations as compared to pre-antibiotic
alues (group A).
However, two weeks later, the peak started to decrease as
he other substantial bacterial groups started to recover, with theal substantial bacterial groups; (C) Pioneer species; (D) Accidental groups
total concentration reaching the initial values at day 100 (Fig. 3C,
Table 2C).
Accidental groups
The accidental bacteria increased when substantial groups
decreased and vice versa. They appeared more often in concen-
trations up to 0.1 × 109 bacteria/mL under antibiotic treatment
and disappeared two to four weeks later (Fig. 3D). Some of the
accidental microbial groups, in particular C. viridae,  Streptococcus,
Staphylococcus and Biﬁdobacterium longum, were detected exclu-
sively in samples during antibiotic treatment, but not before or
after the antibiotic treatment. The marked increase of accidental
bacteria during antibiotic treatment did not add substantially to
the overall colonic biomass because these bacteria occurred in
much lower concentrations compared to the substantial bacteria.
Individual microbial proﬁle
Prior to antibiotic therapy the individual substantial bacte-
rial groups were permanently positive or negative in 93–94%
of the samples. During antibiotic therapy and shortly thereafter,
the occurrence of single bacterial groups in consecutive sam-
ples became unpredictable. The stability recovered with increasing
duration from the end of antibiotic therapy, however, 4 months
after antibiotic therapy the percentage of unstable individual bac-
terial groups remained at 15% in group A patients, and decreased
to the initial value of 7% in both groups of patients receiving Sb.
The antibiotics did not only increase the number of volatile
groups but also changed the composition of individual micro-
bial proﬁles. When consecutive pre-antibiotic measurements were
compared with consecutive monthly measurements at the end of
the study, 43% of individual substantial groups shifted from con-
stantly present to constantly absent, from stable to volatile or vice
versa in group A. The individual microbial proﬁles changed only
12% of the investigated individual bacterial groups in both groups
receiving Sb.
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Table 2
Mean total concentrations × 109 bacteria/mL ± SD.
a b c d e f g h i j k
-60  -30 0 7 14 28 42 56 70 100 >130
A Essential bacterial groups
A I 46 ± 4 48 ± 3.5 47 ± 9 11 ± 7 6.7 ± 3.1 9.7 ± 6.5 14 ± 5 21 ± 8 24 ± 10 31 ± 6 29 ± 9 d to k vs a, b, c
p < 0.01–0.001;
e vs f and d  vs
g  = ns; e vs g
p < 0.001
A/Sb  II 49 ± 5 45 ± 8 51 ± 9.9 25 ± 10 17 ± 4 21 ± 7 24 ± 7 29 ± 9 32 ± 12 41 ± 14 36 ± 6 d to I vs a, b, c
p  < 0.01–0.001;
e vs f p < 0.001;
c vs j, k ns
A Sb III 49 ± 7 49 ± 8 47 ± 6 9 ± 5 5.5 ± 4 16 ± 6 29 ± 8 35 ± 9 37 ± 10 41 ± 10 48 ± 9 d to h vs a, b, c
p < 0.05–0.001;
d, e vs f
p  < 0.001; c vs k
ns
II  vs I, III
p  < 0.001
II vs I, III
p < 0.001
I vs II, III
p < 0.05–0.001
I vs II, III
p < 0.001
I vs II, III
p < 0.001
I vs II, III
p  < 0.001
I vs II, III
p  < 0.001
I vs II, III
p < 0.001
B  Individual substantial bacterial groups
A I 52 ± 24 54 ± 22 50 ± 22 15 ± 14 6.4 ± 4.7 8.2 ± 5.5 14 ± 8.1 18 ± 8.9 19 ± 8.2 20 ± 12 27 ± 14 d, e to k vs a, b,
c p < 0.001; e vs
f  and d vs
g = ns; e vs g
p < 0.001
A/Sb  II 62 ± 26 60 ± 26 57 ± 22 18 ± 12 17 ± 10 26 ± 13 29 ± 12 30 ± 12 35 ± 14 42 ± 16 43 ± 16 d to j  vs a, b, c
p < 0.05–0.001;
e vs f p < 0.02; c
vs k ns
A  Sb III 65 ± 20 69 ± 19 64 ± 16 10 ± 4.4 11 ± 6.4 28 ± 14 54 ± 17 63 ± 13 72 ± 15 75 ± 13 78 ± 14 d to f vs a, b, c
p < 0.001; d, e
vs f p < 0.001;
abc vs h, i, j, k -
ns
I  vs II, III ns I vs II, III ns I vs II, III ns III vs II
p = 0.01
II vs I, III
p = 0.05
- < 0.001
I vs II, III
p < 0.001
I vs II, III
p < 0.001
II vs III
p < 0.001
I vs II, III
p < 0.001
II  vs III
p < 0.001
I vs II, III
p  = 0.002
II vs III
p < 0.001
I vs II, III
p  = 0.03
II vs III
p = 0.002
d, e to k vs
a,  b, c
p < 0.001; e
vs f and d
vs g = ns; e
vs g
p < 0.001
C  Pioneer bacterial groups
A  I 3.2 ± 3.4 3.5 ± 3.2 4.3 ± 4.6 0.9 ± 1.8 1.1 ± 1.3 7.3 ± 5.9 4.9 ± 5.3 4.8 ± 5.3 2.2 ± 2.5 2.2 ± 1.9 2.5 ± 2.7 f vs a, b, c, d, e,
g, h, i, j, k
p < 0.05–0.001
A/Sb  II 4.4 ± 5.1 4.3 ± 5.3 4.3 ± 5.3 1.7 ± 2.9 2 ± 4.9 3.1 ± 5.9 8 ± 7 4 ± 4 4 ± 3.8 2.5 ± 2.8 3.6 ± 3.5 g vs a, b, c, d, e,
f,  h, i, j, k
p < 0.05–0.001
A Sb II 3.2 ± 3.6 5.5 ± 3.9 3.6 ± 2.9 0.6 ± 1 0.5 ± 0.5 3.7 ± 4.4 8.6 ± 7.5 4.5 ± 4 3 ± 1.6 5.2 ± 3.9 5 ± 3.7 g vs a, b, c, d, e,
f,  h, i, j, k
p < 0.05–0.001
I  vs II, III
p  < 0.05
I vs III
p < 0.05
I vs III
p = 0.05
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Fig. 4. Shifts in spatial distribution of bacteria following antibiotic treatment and convalescence. Four cylinders from patient NG in group A collected at day −30, 14, 28, 130
(A,  B, C, D) hybridized with the Fprau (Faecalibacterium prausnitzii) Cy3 (orange ﬂuorescence) probe: (A) Bacteria are highly concentrated and homogeneously distributed over
the  stool cylinder except in the separating mucus layer (magniﬁcation ×100). (B) Bacteria have disappeared from most parts of the fecal cylinder during antibiotic treatment.
Single cells can still be seen in the transition area between the mucus layer and the fermentation area (magniﬁcation ×1000). (C) The recovery of bacteria after cessation of
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fter  antibiotic therapy, bacteria spread over the whole surface of the fecal cylinder
magniﬁcation ×1000).
patial aspects of bacterial distribution during and post-antibiotic
reatment
Shifts in the distribution of substantial bacterial groups were
rincipally the same for essential, individual and pioneer groups;
owever, they were quite different for the accidental groups.
The antibiotics suppressed ﬂuorescence and the concentra-
ions of substantial bacteria mainly in the central area of the
ecal cylinder, however, representatives of the same groups could
emain in low concentrations within the transitional area, after
hey completely disappeared in the fermentation area (Fig. 4B–D).
onversely, restitution started ﬁrst in the transitional area after
ntibiotic treatment (Fig. 4C).
The concentration of reviving substantial bacterial groups
ithin the transition area often exceeded two- to tenfold the con-
entration in the same patient prior to antibiotic treatment. Despite
his local outburst, the overall concentrations of bacterial groups
n the ﬁrst stool sample after antibiotic treatment were low, since
acterial concentrations in the fermentation area remained low or
bsent (Fig. 4C). With increasing time from the antibiotic treat-
ent, a wave of bacterial growth spread over the cylinder with
acterial concentrations equalizing between the transitional and
ermentation area (decreasing in the transitional and increasing in
he fermentation area, Fig. 4D). The total concentrations of bacterial
roups in the fecal cylinder increased accordingly.
The increase in local bacterial concentrations in the transitional
rea and their spread toward the center of the fecal masses were
ypical also for patients receiving Sb.
No gradients in distribution over the fecal cylinder were
bserved for accidental bacteria at any time.y exceed the pre-antibiotic values (magniﬁcation ×400). (D) With increasing time
he concentrations between the transitional and fermentation area become similar
Discussion
In medicine, the colon is associated with multiple diseases, such
as carcinoma, adenoma, appendicitis, diverticulitis, peritonitis, ﬁs-
tula, abscesses, inﬂammatory bowel disease, ileus, megacolon,
diarrhea and constipation, among others. The only positive clin-
ical features are convenient stool frequencies and consistencies.
Therefore, the question has to be asked as to why evolution would
preserve such a risky organ.
In fact, the reason is simple and evident because the colon is a
sophisticated bioreactor. The modern industrial bioreactors that
produce drugs, foods or clear toxic waste achieve concentrations
of approximately 1010 bacteria/mL for limited periods of time.
The colonic bioreactor is far more advanced and maintains con-
centrations of approximately 1012 bacteria/mL for years and uses
more than 5000 different species for fermentation [12]. Obviously,
nature discovered and perfected colonic bioreactors long before
bio-engineering. The merits are impressive because, in humans,
the colon contributes to energy balance via butyrates and short
chain fatty acids, and it is important in prevention of multiple
metabolic disorders, such as diabetes mellitus type II and obesity,
amongst others. In the horse and rabbit, the fermentation products
of the colonic microbiota cover up to 80% of the hosts’ energy
requirements. The colonic bacteria also produce vitamins [7]. Our
ancestors lived on unbalanced mono-diets for long periods of time
and colonic bio-fermentation would have been a powerful tool to
compensate for any deﬁciencies, and there are many well-known
examples from the animal kingdom that demonstrate this.
Furthermore, the colon is one of the central organs for immune
competence – a comprehensive library of complex antigens, which
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an all be handled without dangerous contact with associated
athogens [8]. However, the colon develops its function through
 complex polymicrobial biomass, which the currently available
nalytical tools have difﬁculties to monitor. Previous studies were
ainly aimed at microbial identiﬁcation, ﬁrst by culture, and
ater by culture-independent methods [4,6,12]. The microbiomes
ere regarded as independent players, occupying a colonic niche
ccording to their intrinsic properties and thus contributing
o health or disease. Nevertheless, this can be regarded as an
versimpliﬁcation, since there is no precedence in wildlife where
acteria achieve comparable concentrations and complexity
s they do in the colon or any other evolutionary comparable
rgans. All vertebrates have a colon and the colonic microbiome
s acquired. However, despite similar environments and feeding
nder controlled breeding conditions, each species maintains its
peciﬁc microbial proﬁle. Obviously, the microbes do not drive the
olon, but the colon selects, forms, facilitates and protects the bac-
erial biomass according to its functional goals and environmental
vailability in a process of mutual coevolution [5].
Our data emphasize this remarkable ability of the colon to
aintain species and an individual speciﬁc, highly concentrated
acterial mass over a long period of time.
In this study, greater than 1011 bacteria/mL were detected
hen 142 different bacterial groups were simultaneously moni-
ored by FISH. However, the total concentration of colonic bacteria
ecreased tenfold after two weeks antibiotic treatment with
iproﬂoxacin and metronidazole. The remaining concentration
as, however, higher than 1010 bacteria/mL, which is still more
han most laboratory bioreactors achieve.
It could be supposed that some of the bacteria within the enor-
ous diversity of the colonic microbiome were antibiotic-resistant,
nd re-occupied the vacated niches of eliminated competitors
eeping the total concentration high; however, there were no
ndications for such displacement within two weeks of antibiotic
herapy. Within the spectrum of applied FISH probes, the residual
iomass was composed of preexisting substantial microbial groups,
ost of which were suppressed and none increased.
The astonishing resilience of the colonic microbiome is inex-
licable in terms of microbial composition or bacterial resistance
o antibiotics. Therefore, the colon’s function has to be included in
valuating the microbiome.
In the present study, the structure of bacterial growth was inves-
igated in relation to the colonic wall in sections of fecal cylinders.
patially, this bioreactor was composed of three areas: separating
ucus, a transitional area, and a fermentation area. The digestive
eftovers and bacteria were peristaltically stirred and fermented in
he fermentative area. However, the role of mucus and its layers is
ore complex, since water and electrolyte resorption solidify the
ucus. The positive viscosity and negative osmotic gradient are
ighest close to the colonic wall, making mucus impenetrable for
acteria [14]. The impenetrable mucus layer separates mucosa from
he colonic microbiota, which is already important in a normally
unctioning bioreactor, since the highly diverse colonic biomass
nvariably includes potentially life threatening pathogens, such as
acteroides fragilis,  Clostridium perfringens, Enterobacteriaceae and
thers. However, this is even more important in the case of the
resence of speciﬁc enteric infectious agents, such as Shigella and
ersinia enterocolitica.
The role of the mucus layer, however, exceeds mechanical
eparation because it is also decisive in attraction, shelter and
acilitation of microorganisms [17]. These latter issues are pre-
ogatives of the transitional mucus layer, since, with increasing
istance to the colonic wall, the mucus becomes increasingly
egraded, softened and penetrable for bacteria. Substantial bac-
erial groups occupy speciﬁc levels within this 10–30 m thick
and according to their ability to move in a viscous environment.ied Microbiology 39 (2016) 67–75
The mucus, however, remains viscous enough to be moved along
by peristalsis, and it remains part of the mucus layer forming
the transitional area. The presence of bacteria within the mucus
divides the transitional area from the separating mucus lacking
bacteria. The homogeneous texture and absence of digestive
leftovers marks the border between transitional mucus and the
stirred fermentation area on the luminal side.
The distribution of bacteria in transitional mucus in healthy
individuals and during antibiotic treatment discloses the crucial
role of this anatomic structure in steering the colonic bioreactor.
The transitional mucus layer contained no digestive leftovers.
Nevertheless, substantial bacterial groups increased to their maxi-
mum concentrations, and luminescence of FISH was highest within
the transitional layer, suggesting that bacteria were not passively
inﬁltrating the mucus, but were actively attracted and facilitated
by the host. The attraction was  not general but was  restricted to
selected bacterial strains, which were host-species-speciﬁc, as in
the case of the essential bacterial groups, or person-speciﬁc, as in
the case of all individual substantial bacterial groups. Accidental
bacteria preferred the rich digestive leftover fermentation area, had
no commitment to mucus and were unpredictable in consecutive
measurements.
The “rooting” of substantial bacterial groups in the “topsoil” of
the transitional mucus associated the bacteria of interest with a
stable individual microbial proﬁle, and sheltered them from eradi-
cation through antibiotics. While antibiotic suppression was  most
severe in the central portion of the fecal cylinder, the substan-
tial bacterial groups prevailed within the transitional area after
they completely disappeared everywhere else in the fecal cylinder.
After discontinuing the antibiotic, one would expect rapid growth
in the area of maximum availability of nutrients. Accidental bacte-
ria, which were presumably located within the fecal stream, should
have maximum advantage. Nevertheless, the opposite was the case,
although the occurrence of accidental bacteria increased during
antibiotic treatment and then disappeared after discontinuation of
the antibiotics. In fact, the middle of the fecal stream was  quickly
occupied by pioneer species of Biﬁdobacteriaceae,  Enterobacteri-
aceae and the Clostridium difﬁcile groups. The pioneer bacteria
increased exponentially to concentrations signiﬁcantly exceeding
the pre-antibiotic values and declined as soon as the fecal cylinder
was occupied by other less quickly recovering substantial bacterial
groups. The recovery after antibiotic treatment did not start in the
center of the fecal stream but within the transitional area. Concen-
trations of recovering substantial groups in this area exceeded the
pre-antibiotic values, although they remained absent in the fer-
mentation area. The local concentrations in the transitional area
declined with the spread of bacteria over the fermentation area,
and with bacterial distribution equalizing in the fecal cylinder.
Bacterial concentrations of less than 104 bacteria/mL cannot
be reliably detected by FISH, since the volume of the 4 m thick
and 4 mm × 4 mm large fecal section is too small. Disappearance of
substantial groups during antibiotic treatment in FISH investiga-
tions does not automatically imply their eradication throughout
the colon. However, individual substantial groups that became
undetectable under antibiotic treatment did have considerable dif-
ﬁculties to recover, revealing close interdependence between the
stability of the microbial proﬁle and the overall output of the fer-
mentative biomass.
After antibiotic treatment, the diversity of the colonic micro-
biome and the total number of bacteria was reduced, and some of
the individual substantial bacterial groups could not be revived.
The diversity increased through acquisition of new individual sub-
stantial groups. As a result, 43% of the initial individual microbial
proﬁle changed. Under this circumstance, the total output of the
colonic bioreactor recovered slowly and the concentrations at the
end of the observation period still remained signiﬁcantly below
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re-antibiotic values reaching approximately 60% of the initial
oncentrations. Obviously, the re-composition of the individual
icrobial proﬁle needed time-consuming complex adjustments
hat led to a reduction of the fermentative performance.
The decrease in the concentrations of the fermenting biomass
nd inconsistency of the bacterial diversity were effectively averted
y Sb prophylaxis. A total of 88% of patients receiving Saccharomyces
oulardii CNCM I-745 quickly restored their initial individual
icrobial proﬁles. The total microbial concentrations recovered
ompletely in the two Sb groups within 3 months post antibi-
tic. However, although they were different shortly after antibiotic
reatment, both concomitant and subsequent Sb-treated groups
ere similar at the end of the observation period.
Many lines of reasoning could explain the observed protective Sb
ffects. For instance, it is commonplace that most microbial culture
edia include yeast extract as a component for promoting bacterial
rowth. However, most intriguing is the recently described uti-
ization of yeast mannan by bacteria through a selﬁsh mechanism
2]. Mankind has applied fermentation processes for thousands
f years. Saccharomyces is one of the main fermentative agents
esponsible for bread, beer, wine and vinegar products. Neverthe-
ess, the interactions of yeast and human microbiota are probably
ore complex than we presently assume and still have to be
nraveled.
However, this study has shown that the functional anatomy of
he colonic bioreactor provides transparent criteria for the direct
ssessment of colon-microbiome interactions and the perturba-
ions caused by antibiotics.
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